Gene Therapy Seen to Raise Response to Levodopa Given as IV Infusion in Trial

An investigational gene therapy, called VY‐AADC01, boosts motor responses to levodopa that is given intravenously —particularly at a low dose — in people with Parkinson’s disease, a sub-study within a Phase 1b trial shows. These findings, along with positive data from the main PD-1101 study (NCT01973543), support the potential…